CAMPTON Diagnostics GmbH has been founded to conduct this initiative by taking care of the certification, production, delivery and maintenance of the technology worldwide.
Shareholders of the company are the team members.
CAMPTON Diagnostics GmbH was spun off from the Fraunhofer Institute for Silicon Technology (ISIT) in Itzehoe in 2016.
The company develops and markets complete measuring systems for point-of-care diagnostics, i.e. for on-site examinations of patients. CAMPTON Diagnostics combines biotechnological and engineering know-how under one roof.
The “Biochip Reader” device developed by CAMPTON uses silicon-based biochips from Fraunhofer ISIT. The ISIT produces these in the institute’s own clean room.
The system, which is based on “electrical biochip technology”, can be used to obtain reliable information on the indication of infections, cancer or other diseases from a drop of whole blood within a few minutes. The tests are particularly fast, highly sensitive and enable the simultaneous measurement of several parameters in one sample.
Disposable cartridges with an integrated biochip are used for the measurements. The biochip functions like a conventional ELISA test, but is electrically readable and therefore extremely miniaturizable. The “Biochip Reader” performs the measurement fully automatically. After a few minutes, the analysis result is shown on the display as a real value.
CAMPTON Diagnostics has been founded as a spin off out of Fraunhofer ISIT in 2016 by the current Management Team consisting of Lars Blohm, Jürgen Brink and Eric Nebling. In 2019 the German entrepreneur Prof. Dr. Reinhold Würth invested in CAMPTON’s second financing round.
In 2019 the German Würth Group participated in the second financing round of CAMPTON Diagnostics.
About Adolf Würth GmbH & Co. KG
Adolf Würth GmbH & Co KG is a leading specialist in assembly and fastening materials for professional applications. It is the largest individual company of the Würth Group, which operates worldwide. Adolf Würth GmbH & Co KG currently employs over 7,000 people throughout Germany and generated sales of EUR 1.98 billion (including intra-group sales) in the 2018 financial year.
“To enrich lives with meaningful innovations”
CAMPTON aspires to bring life-changing technologies to people in need. We are driven towards creating a value-based healthcare system in the lives of the people we touch every day. We say we are not satisfied that our place or climate determines our right to life and healthcare. We are driven by a three-fold mission: to make the world a little better, more liveable and safer place to live in.
“Celebrating life, confronting death”
CAMPTON aims to empower the lives of all refugees, patients and other people by reducing the time cost of health care for patients because we see equal value in all lives. With the Point-of-Care system, CAMPTON aims to turn immediate healthcare for all into a basic right and not a privilege. To achieve this objective, our cornerstones are: Efficiency, Mobility, Speed and Competency.
Managing Director / CEO
Mr. Brink is responsible for the Finance/Legal/Personnel/IT department within CAMPTON Diagnostics GmbH.
Mr. Brink is also managing partner of the entrepreneurial consultancy brink.corporate development GmbH, which specializes in the areas of “corporate strategy, company acquisitions and sales (M&A) and financing with equity and debt capital”.
Prior to this, Mr. Brink worked for many years as a project manager in various banks and an international auditing firm, where he was responsible for projects in the areas of “acquisition and project financing, M&A transactions and IPO consulting”. As Director of Corporate Development/M&A of one of the larger German family-owned companies, he was able to develop an investment portfolio of approximately 500 companies worldwide.
Dr. Eric Nebling
Managing Director / CSO
Dr. Eric Nebling studied Chemistry in Hamburg (Germany) and did his PhD work in the department of biochemistry of the university of Hamburg in the biosensor field. He works at Fraunhofer ISIT in the department “Biotechnical Microsystems (BTMS)” as a research scientist since 1999. He is leader of the group “Biosensor Technology” and deputy head of the department “Module Integration”
Dr. Eric Nebling´s main field of work are protein based tests on electrical biochips. He was co-responsible for the BMBF-funded project “Silicon chip system for the biochemical analysis technique: Technical platform and system integration (SIBANAT)”.
Dr. Nebling was also ISIT´s project leader of the Fraunhofer project “in-vitro-Diagnostic-Platform” (ivD-MAVO and ivD-WISA; internal programs) and the BMBF-funded project “Cellfree Bioproduction”.
Additionally, he has set up several start-up companies as founder and investor in the past.
Managing Director / CTO
Lars Blohm is working as a research scientist in the department “Biotechnical Micro-systems” at the Fraunhofer ISIT since the year 2009. His main field of activity is the construction and development of biotechnical microsystems based on silicon technology. Furthermore, he develops automated measurement systems based on the electrical biochip technology for various analytical and diagnostic applications.
Previously, Mr. Blohm has studied electrical engineering at the West Coast University of Applied Sciences in Heide, Germany, after his training and working as an industrial electronics.
From 2001 to 2009 he worked as graduated engineer in the eBiochip Systems GmbH, a spin-off company of the Fraunhofer ISIT. There he was head of the research and development department and responsible for the development of automated bio-detection systems for pathogen and antibody diagnostics.
Senior Technical Director
Jörg Albers is working as a research scientist at Fraunhofer ISIT.
After finishing a university degree in the field of technical computer science, he first worked in industry as hardware and software developer for several years.
In 1996 he joined the Biosensor Technology Group of ISIT and took responsibility for micro controller based electrochemical readout systems. Further he worked on biosensors research in several national and international projects. Actually his work is focused on the development of different silicon based sensors which are main parts of the automated measurement systems for analytical and diagnostic applications.
In 2003 Simone Holz successfully completed her training as medical-technical laboratory assistant at the Dr. Gillmeister School in Heide.
From 2005 she worked at the Landeslabor Schleswig-Holstein in Neumünster in the veterinary division for animal disease control in molecular biology, serology and pathology.
In 2008 she moved to AJ eBiochip GmbH in Itzehoe, a subsidiary of Analytik Jena AG, where she was involved in the implementation of biochemical and analytical methods. Furthermore, she worked on reagent and kit production as well as method development and device tests for the application of electrical biochips.
From 2011 onwards, Ms Holz worked at Fraunhofer ISIT. There she was involved in the development of mobile biosensor systems for protein detection on biochips. She also works on the optimisation and validation of automated immunoassays and lab-on-chip systems. Furthermore, her area of responsibility included the coating of biochips using piezo nanoplotters and the organisation of general laboratory operations.
Simone Holz has been working as a medical laboratory assistant at CAMPTON Diagnostics GmbH since 2019.
Lars Johansen studied Biomedical Engineering with strong focus on quality management at the Technical University Berlin.
Starting 2001 until 2017 he worked in various product and process related positions in quality management at SIEMENS Healthcare GmbH, Erlangen. Especially to mention 7 years as manager and as quality management representative and safety officer.
Afterwards he joined the European headquarter of the in-Vitro-Diagnostic manufacturer Sysmex to further improve the quality management system.
In 2019 Lars Johansen joint CAMPTON Diagnostics as quality manager and is responsible for the implementation and successful certification of the quality management system.
Dr. Stephanie Kesgin-Schäfer
Dr. Stephanie Kesgin-Schäfer studied Microbiology and Biochemistry at the Georg-August-University in Göttingen. For her Master Thesis she joined the department of biophysical chemistry at the Max-Plank-Institute in Göttingen. Afterwards she received a PhD in Chemistry from the University of Hamburg for her research in the department of biochemistry in the field of protein engineering utilizing unnatural amino acids.
In 2019, Dr. Stephanie Kesgin-Schäfer joined CAMPTON Diagnostics GmbH as a molecular biologists in the R&D department. Her work focuses on the development of molecular biological tests based on electronical biochips and the construction and testing of bioanalytical microsystems for diagnostics.
Head of R&D Electronics
Mats Rasmussen graduated his university studies as an electrical engineering with a strong focus on microtechnologies and electronic systems at the West Coast University of Applied Sciences in Heide, Germany. Before that, he trained and worked as an electronics technician for four years.
After that, he studied microelectronic systems at the cooperative degree program of the West Coast University of Applied Sciences in Heide and the University of Applied Sciences in Hamburg, Germany. He wrote his final thesis at the Fraunhofer Institute of Silicon Technologies ISIT in Itzehoe about the development of a measuring electronic for a multi-parametric sensor chip to monitors various parameters in liquid fluids.
In October 2019 Mats Rasmussen joined CAMPTON Diagnostics as a development engineer and is responsible for the research and development of electronics.